Enlivex Therapeutics Ltd (ENLV) stock is down -68.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ENLV stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 11. ENLV's rank also includes a short-term technical score of 23.
ENLV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ENLV!
Enlivex Therapeutics Ltd (ENLV) stock is lower by -1.46% while the S&P 500 is up 0.1% as of 10:28 AM on Friday, Oct 27. ENLV is down -$0.02 from the previous closing price of $1.31 on volume of 21,414 shares. Over the past year the S&P 500 is higher by 8.77% while ENLV is down -68.92%. ENLV lost -$1.63 per share in the over the last 12 months.
Click Here to get the full Stock Report for Enlivex Therapeutics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
